Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideJNJJohnson & Johnson
FinDog View：Bullish
VRTXVertex Pharmaceuticals
FinDog View：Neutral
| Metric | JNJ | VRTX |
|---|
| Close | 267.28 | 513.26 |
| Market Cap | $644B | $121B |
| 1M | +1.87% | −0.44% |
| P/E (TTM) | 30.6 | 29.7 |
| Forward P/E | 20.7 | 24.0 |
| P/E 5-Yr Percentile | 90 | 52 |
| P/S | 6.6 | 10.4 |
| P/B | 7.6 | 6.5 |
| Dividend Yield | 3.12% | — |
| Latest Quarter Revenue | $25.3B | $3.3B |
| Revenue YoY | +6.6% | +12.5% |
| Gross Margin | 68.2% | 85.3% |
| Latest Quarter EPS | 2.27 | 4.31 |
| Avg Post-Earnings Move | ±0.6% | ±6.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.25% | 1.66% |
| 90-Day Net Insider Buying | −$67.8M | −$2.8M |
JNJ · Revenue, Last 8 Quarters ($B)
VRTX · Revenue, Last 8 Quarters ($B)
